Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    1869452 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Amifostine trihydrate;   Radiation: Radiation therapy
2 Active, not recruiting Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: < 15% risk of + LN;   Radiation: > 15% risk of + LN

Indicates status has not been verified in more than two years